SIGMA 7 PRODUCTS INC
10QSB, 1997-02-18
BLANK CHECKS
Previous: SIGMA 7 PRODUCTS INC, 10QSB, 1997-02-18
Next: VERSUS TECHNOLOGY INC, 8-K, 1997-02-18




<PAGE>  


                  SECURITIES AND EXCHANGE COMMISSION
                       Washington, D.C.  20549


                            FORM 10-QSB




Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934


                  For Quarter Ended June 30, 1996


                     	Commission File No. 0-17700




                         SIGMA-7 PRODUCTS, INC.
          (Exact name of Registrant as specified in its charter)


            COLORADO                                84-1095500
 (State or other jurisdiction of              (I.R.S. Empl. Ident. No.
                                           incorporation or organization)


   2501 East 3rd Street
     Casper, Wyoming                                 82609
(Address of Principal Executive Offices)           (Zip Code)


                               (307) 235-0012
            (Registrant's Telephone Number, including Area Code)




Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or such shorter period that the Regis-
trant was required to file such reports), and (2) has been subject to such
filing to such filing requirements for at least the past 90 days.

                     Yes               No   X  

The number of shares outstanding of each of the Registrant's classes of
common equity, as of June 30, 1996 are as follows:


      Class of Securities                        Shares Outstanding
   Common Stock, no par value                        756,042,241



<PAGE>

                                    INDEX


                                                                Page of
                                                                Report
        PART I.	FINANCIAL INFORMATION

Item 1.	Financial Statements.

        Balance Sheets:

          As of June 30, 1996 (Unaudited) and
          September 30, 1995...................................... 3

        Statement of Operations (Unaudited):

          For the three months ended June 30, 1996 
          and Cumulative from inception (October 3, 1988)
          through June 30, 1996................................... 4

        Statements of Cash Flows (Unaudited): 

          For the three months ended June 30, 1996 
          and Cumulative from inception (Octobrt 3, 1988)
          through June 30, 1996................................... 5

        Notes to Financial Statements (Unaudited)................. 6


Item 2.	Management's Discussion and Analysis or
        Plan of Operation......................................... 7



        PART II.	OTHER INFORMATION

Item 6.	Exhibits and Reports on Form 8-K.......................... 8


        Signatures................................................ 8



<PAGE>


Item 2.	Management's Discussion and Analysis or Plan of Operation.

  Background.  The Company was incorporated in the State of Colorado under the
name of Seek-2 Ventures, Inc. on October 3, 1988 as a blind pool corporation
for the purpose of obtaining capital to take advantage of domestic and
foreign business opportunities. On April 13, 1989, the Company completed its
initial public offering of 11,460,000 shares of stock raising the approximate
net sum of $93,467.

  On April 19, 1989, the Company amended its Articles of Incorporation chang-
ing the Company's name to Sigma-7 Products, Inc.  Subsequently, on January
25, 1992 the Company changed its name to Global Development Group, Inc.

  During the period between April 19, 1989 and approximately March 1, 1991,
the Company engaged in the manufacture of electronic self-protection devices
commonly referred to as "stun-guns".  During 1991 the Company determined that
pursuing the stun gun manufacturing business would require substantially more
funds than it could reasonably expect to raise in the near future,  Further,
various economic, governmental and regulatory agencies brought focus on the
industry in such a manner that it did not appear to be in the Company's best
interest to pursue this endeavor. During late February and early March 1991,
the Company ceased to operate that business due to a lack of working capital
and extended debt.

  Subsequent to January 1, 1991, the Company engaged in a financial restruct-
uring to eliminate as much debt as possible and to make the Company attrac-
tive for acquisition and/or merger with qualified individuals and companies
with existing operations.

  The Company's sole business at this point is to seek to acquire assets of
or an interest in a small to medium-size company or venture actively engaged
in a business generating revenues or having immediate prospects of generating
revenues. The Company plans to acquire such assets or shares by exchanging
therefor the Company's securities. In order to avoid becoming subject to
regulation under the Investment Company Act of 1940, as amended, the Company
does not intend to enter into any transaction involving the purchase of
another corporation's stock unless the Company can acquire at least a majority
interest in that corporation. The Company has not identified any industry,
segment within an industry or type of business, nor geographic area, in which
it will concentrate its effort, and any assets or onterest acquired may be in
any industry or location, anywhere in the world. The Company will give
preference to profitable companies or ventures with a significant asset base
sufficient to support a listing on a national securities exchange or quota-
tion on the NASDAQ system. Members of management (all of whom are devoting
part time to the Company's affairs) plan to search for an operating business
or venture which the Company can acquire, thereby becoming an operating
company. There is no assurance that the Company will be succesful in this
endeavor. The Company has no operations or source of revenues. Unless the
Company succeeds in acquiring a company or properties which provide cash
flow, the Company's ability to survive is in doubt.

  Financial Condition.  During the quarter ended June 30, 1996 (third
quarter of this year), the Company had no revenues and did not have
operations. Expenses for this period were minimal, resulting in a loss of
$522. The Company has, since inception, accumulated a deficit (net loss)
through the end of this quarter of $449,692.

  Liquidity and Capital Resources.  The Company had $1,744 cash on hand at the
end of the quarter. The Company had no other cash or other assets, nor any
current plans to raise capital. Whether the Company ultimately becomes a
going concern depends upon its success in finding and acquiring a suitable
private business and the success of that acquired business. At this time, the
Company has no commitment for any capital expenditure and foresees none.
Offices are provided without charge to the Company. However, the Company will
incur routine fees and expenses incident to filing of reports with the
Securities and Exchange Commission, and it will incur fees and expenses in
the event it makes or attempts to make an acquisition. As a practical matter,
the Company expects no significant operating costs other than professional
fees payable to attorneys and accountants.

<PAGE>
 
  In regard to a proposed acquisition, the Company anticipates requiring the
target company to deposit with the Company a retainer which the Company can
use to defray such professional fees and costs. In this way, the Company
could avoid the need to raise funds for such expenses or becoming indebted to
such professionals. Moreover, investigation of business ventures for poten-
tial acquisition will involve some costs, at the least postage and long-
distance telephone charges. Management hopes, once a candidate business
venture is deemed to be appealing, to likewise secure a deposit from the
business venture to defray expenses or further investigation, such as air
travel and lodging expenses. An otherwise desirable business venture may,
however, decline to post such a deposit.
 
  The Company has no credit available to it and is unable to borrow money.
Management does not anticipate raising funds through the sale of securities
or otherwise, and it is unlikely that significant funds could be raised in a
securities offering, in any event. This inability to raise funds could
negatively affect the Company's realization of its business purpose.



<PAGE>
         	
Board of Directors
SIGMA-7 PRODUCTS, INC.
Cheyenne, Wyoming


The accompanying balance sheet of SIGMA-7 Products, Inc. (a development
stage company) as of June 30, 1996 and the related statements of opera-
tions and cash flows for the three month period ended December 31, 1995 and
for the period from inception (October 3, 1988) to June 30, 1996 were not
audited by us, and accordingly, we do not express an opinion on them.
  
The financial statements do not contain all of the disclosures required by
generally accepted accounting principles.  If the required disclosures were
included, they might influence the user's conclusions about the Company's
financial position, results of operations and cash flows.

The financial statements for the year ended September 30, 1995, were audited
by us and we expressed an unqualified opinion on them in our report dated
January 23, 1996, but we have not performed any auditing procedures since
that date.


LEVINE, HUGHES & MITHUEN, INC.


Englewood, Colorado
August 5, 1996


<PAGE>

                         SIGMA-7 PRODUCTS, INC.
                      (A DEVELOPMENT STAGE COMPANY)
                             BALANCE SHEETS


                                	ASSETS

                                        June 30,             September 30,
                                          1996                      1995
                                      ------------             -------------
                                      (Unaudited)                  (Note)
Current assets:
 
  Cash                                $     1,744              $        500
                                      ============             =============


                  LIABILITIES AND STOCKHOLDERS' EQUITY:


Current liabilities:

  Accounts payable                    $     6,351              $        443
  Notes payable                             5,000                     5,000
  Accrued interest                          6,228                     5,553
                                      ------------             -------------
    Total current liabilities              17,579                    10,996


Stockholders' equity:

  Preferred stock, no par value,
    10,000,000 shares authorized;
    none issued and outstanding
  Common stock, no par value;
    1,000,000,000 shares authorized;
    756,042,241 and 744,042,291 shares 
    issued and outstanding at June 30, 
    1996 and Sep. 30, 1995. (Note 2)      419,489                   418,289
  Contributed capital                       8,250                     6,250
  Deficit accumulated during the 
    development stage                    (443,574)                 (435,035)
                                      ------------              -----------
 
  Total stockholders' (deficit)           (15,853)                  (10,496)
                                      ------------              -----------
                                      $     1,744               $       500
                                      ============              ============

Note:   Taken from the audited balance sheet at that date.



<PAGE>
                            SIGMA-7 PRODUCTS, INC.
                        (A DEVELOPMENT STAGE COMPANY)
                          STATEMENTS OF OPERATIONS


                                                              October 3, 1988
                          Three months        Nine month          (Inception)
                             Ended               Ended                To
                          June 30, 1996      June 30, 1996     June 30, 1996
                          -------------      -------------    ---------------
                           (Unaudited)        (Unaudited)       (Unaudited)

Revenue                   $          -       $          -            20,966

Operating expenses:

  General and admin.              (747)             7,864           485,649
  Interest expense                 225                675            35,919
  Amortization                       -                  -               250
                          -------------      -------------    --------------
                                  (522)             8,539           521,818

Other income                         -                  -            51,160
                          -------------      -------------    --------------
Income (loss) before 
  extraordinary item:              522             (8,539)         (449,692)

Extraordinary items:

  Gain on conversion of 
    debt to equity                   -                  -             6,118
                          -------------      -------------    --------------
Net income (loss)        $         522       $     (8,539)    $    (443,574)
                         ==============      =============    ==============


Net loss per share       $          *        $          *     $           *
                         ==============      =============    ==============


Weighted average
  number of common
  shares outstanding      754,899,434         754,899,434       285,440,601
                         =============       =============    ==============




* less than $.01 per share.



<PAGE>
                          SIGMA-7 PRODUCTS, INC.
                       (A DEVELOPMENT STAGE COMPANY)
                         STATEMENTS OF CASH FLOWS


                                                                Oct. 3, 1988
                                 Three Months    Nine Months     (Inception) 
                                     Ended           Ended            To
                                June 30, 1996   June 30, 1996   June 30, 1996
                               ---------------  --------------  --------------
                                 (Unaudited)     (Unaudited)     (Unaudited)
Cash flows from operating
  activities:

  Net (loss) income            $       522     $    (8,539)     $  (443,574)

  Adj. to reconcile net
   income(loss) to net cash 
   provided by operating 
   activities:

   Amortization                          -                -              250

Cash provided (used) due to 
  changes in assets and 
  liabilities:

  Issuance of common stock
   for services                          -            1,200           42,700
  Other income                           -                -          (51,160)
  Accounts payable                       -            5,908           44,019
  Accrued interest and exp.            225              675           18,509
                                -----------     ------------     ------------

Net cash used by operating 
  activities                           747             (756)        (389,256)
                                -----------     ------------     ------------

Cash flows from financing actvts:

  Net proceeds from issuance
   of common stock: 
    For cash                            -                 -          195,405
    For conversion of debt              -                 -          198,706
  Increase in notes payable             -                 -            6,213
  Deferred offering costs               -                 -          (17,324)
  Contributed capital                   -             2,000            8,250
  Increase in org. costs                -                 -             (250)
                               -----------      ------------     ------------

Net cash provided by financing
  activities                          747             2,000          391,000
                               -----------      ------------     ------------

Net increase in cash
  and cash equivalent                 747             1,244            1,7447
                               -----------      ------------     ------------
Cash and cash equivalents,
  beginning of period                 997               500                -
                               -----------      ------------     ------------

Cash and cash equivalents,
  end of period                $    1,744       $     1,744      $     1,744
                               ===========      ============     ============


<PAGE>

                          SIGMA-7 PRODUCTS, INC.
                      (A DEVELOPMENT STAGE COMPANY)
                      NOTES TO FINANCIAL STATEMENTS



NOTE 1:	CONDENSED FINANCIAL STATEMENTS

  The financial statements included herein have been prepared by SIGMA-7
Products, Inc. (the "Company") without audit, pursuant to the rules and
regulations of the Securities and Exchange Commission.  Certain information
and footnote disclosures normally included in financial statements prepared
in accordance with generally accepted accounting principles have been
condensed or omitted as allowed by such rules and regulations, and the
company believes that the disclosures are adequate to make the information
presented not misleading. It is suggested that these financial statements be
read in conjunction with the September 30, 1995 audited financial statements
and the accompanying notes therto. While management believes the procedures
followed in preparing these financial statements are reasonable, the accuracy
of the amounts are in some respects dependent upon the facts that will exist,
and procedures that will be accomplished by the Company later in the year.

  The management of the Company believes that the accompanying unaudited
condensed financial statements contain all adjustments (including normal
recurring adjustment) necessary to present fairly the operations and cash
flows for the periods presented.


NOTE 2:	ISSUE OF COMMON STOCK

  During October, 1995, the Company, with the approval of its Board of
Directors, issued and caused to be delivered 12,000,000 of its common stock
as payment for services rendered to two of its corporate officers and its
legal counsel.


<PAGE>

Part II

Item 6. Exhibits and Reports on Form 8-K.

        (a)  Exhibit 27.
        (b)  Reports on Form 8-K.
               None.

			
                               SIGNATURES

  In accordance with the requirements of the Exchange Act, the Registrant
caused this Report on Form 10-QSB/A to be signed on its behalf by the under-
signed, thereunto duly authorized.


DATED:  February 7, 1997
        SIGMA-7 PRODUCTS, INC.




         /s/ Donald Smith
         By  Donald Smith
         Chief Executive Officer
         and Chief Financial Officer





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission